Evaluate Pharmacokinetics and Safety of Slow Release DHEA

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

March 3, 2023

Primary Completion Date

April 24, 2025

Study Completion Date

April 24, 2025

Conditions
AsthmaGenotype
Interventions
DRUG

Slow Release DHEA

DHEA is a hormone produced by the body's adrenal gland. In drug form, it is available as an over-the-counter supplement that is available on the market without prescription.

Trial Locations (2)

46202

Riley Hospital for Children, Indianapolis

University Hospital, Indianapolis

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

Indiana University

OTHER